Articles By Rachel Tate, DO
Three Healthcare Hashtags You Should Follow
By Rachel Tate, DO
14 September 2021
I've sent more than 2,000 tweets since joining Twitter in July 2010. Even better, I've read (and sometimes shared) thousands of other educational, informative and sometimes humorous tweets from fellow rheumatologists, physicians, healthcare providers and others around the world. While following individuals and organizations relevant to you is important, so is following hashtags. Here are three I recommend.
Read Article
ICYMI: New GRAPPA 2021 PsO and PsA Treatment Recommendations
By Rachel Tate, DO
07 July 2021
The evidence-based recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis were presented at #EULAR2021. The goal (as per 2009 recommendations) was “To develop recommendations, based upon the best scientific evidence, for the optimal treatment of patients with PsA” Dr. Laura Coates, Oxford detailed in abstract #OP0229. Since the last update in 2015, there have been multiple changes, which are highlighted here.
Read Article
Q-DAPSA for Measuring Disease Activity in PsA
By Rachel Tate, DO
10 June 2021
Given its multiple domains, there remains much discussion over the best disease activity scoring method in PsA. The proverbial "holy grail" would be a measure that is quick, intuitive, domain comprehensive and validated.
Read Article
New GRAPPA 2021 PsO and PsA Treatment Recommendations
By Rachel Tate, DO
04 June 2021
The evidence-based recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis were presented at #EULAR2021.
Read Article
HLA B27 Iritis - RNL 2021 Highlights
By Rachel Tate, DO
31 March 2021
The Spondyloarthritis Advances pod presented during the RheumNow Live 2021 conference featured three speakers, including an excellent lecture by Dr. Robert Wang, ophthalmology, on HLA B27 iritis and practical tips for rheumatologists.
Read Article
RWCS Highlights - Day 4
By Rachel Tate, DO
16 February 2021
As another year at RWCS in Maui wrapped up, I’m so thankful I had the opportunity to participate remotely. Here are my day 4 #RWCS2021 pearls from the Novel Therapies Year in Review (RA, SLE, OA); novel concepts in pediatric rheumatology; and post-COVID telerheumatology sessions.
Read Article
RWCS Highlights - Day 3
By Rachel Tate, DO
15 February 2021
Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.
Read Article
RWCS Highlights - Day 2
By Rachel Tate, DO
12 February 2021
As I attend RWCS virtually, I am always amazed by the amount of thought that goes into preparing great talks geared toward busy clinicians. Today, I am highlighting a few more pearls that you may find interesting as well.
Read Article
RWCS Highlights - Day 1
By Rachel Tate, DO
11 February 2021
The 2021 Rheumatology Winter Clinical Symposium launched yesterday as a hybrid meeting. As always, this conference lends itself to data for the practical clinician. Here are my pearls about new developments in RA, checkpoint inhibitors and IV IgG taken from several sessions presented on Day 1.
Read Article
ACIP Recommendations for Pfizer Vaccine Candidate
By Rachel Tate, DO
07 December 2020
The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.
Read Article